Thrombospondin ( Immunohistochemical studies from our laboratories indicate that thrombospondin exists in a variety of bone marrow cells other than megakaryocytes (vide infra). However, little is known concerning the function of this molecule in the hematopoietic microenvironment. We report that thrombospondin plays an important role as a cytoadhesion molecule involved in processes underlying hematopoietic cell proliferation and/or differentiation. 
T influence the growth and differentiation of blood cells.
Although poorly defined, this microenvironment is composed of both cellular and extracellular components. In long-term bone marrow cell cultures, the maintenance of hematopoiesis is dependent on the establishment of an intact layer of adherent cells derived from the marrow stromal cells.'-* Such hematopoietic accessory cells elaborate soluble factors that influence hematopoietic proliferation and differentiati~n,~ as well as synthesize and deposit extracellular matrix components such as laminin, collagen, and glycosaminoglycan^.^^^ However, little is known about the molecular mechanism by which developing blood cells are retained within the bone marrow, or by which transplantable hematopoietic stem cells home to or lodge within the bone marrow. Relevant locales in which such a cytoadhesive property might be found within the hematopoietic microenvironment are the bone marrow stromal cells themselves, or components of the bone marrow extracellular matrix.
Thrombospondin (TSP) is a large trimeric disulfide-linked glycoprotein (subunit molecular weight on sodium dodecyl sulfate-polyacrylamide gel electrophoresis [SDS-PAGE] is 180,000). Thrombospondin, like fibronectin, is a modular glycoprotein having a domain-like structure.6 These proteaseresistant domains mediate one or more TSP interactions.
These include the binding of cells, calcium, glycosaminoglycans, fibrinogen, fibronectin, plasminogen, plasminogen activator, and type V collagen. Thrombospondin is synthesized by a variety of cells including endothelial cells, fibroblasts, keratinocytes, smooth muscle cells, carcinoma cells, glial cells, megakaryocytes, and type I1 pneumocytes (reviewed in reference 6 ) . Synthesized TSP is secreted and incorporated into the extracellular matrix, and matrix-bound TSP is necessary for cell adhesion,' cell growth,' and carcinoma cell invasiveness? Immunohistochemical studies from our laboratories indicate that thrombospondin exists in a variety of bone marrow cells other than megakaryocytes (vide infra). However, little is known concerning the function of this molecule in the hematopoietic microenvironment. We report that thrombospondin plays an important role as a cytoadhesion molecule involved in processes underlying hematopoietic cell proliferation and/or differentiation. 
METHODS
Proteins (unless otherwise stated, 20 pg/mL) in serum-free RPMI media were immobilized onto tissue culture plastic by incubation at 37°C for 1 hour. Subsequently, nonspecific plastic binding sites were blocked by incubating (30 minutes at 37°C) with 10 mg/mL bovine serum albumin (BSA) in RPMI 1640 (GIBCO, Grand Island, NY). The immobilized protein was washed twice with fresh RPMI and incubated with washed cells (5 x lo5 mL suspended in RPMI containing 1% BSA) for 15 minutes at 37°C. Suspension (ie, nonadherent) cells were removed by aspiration, dishes were washed twice with RPMI, adherent cells were removed with the aid of a rubber policeman, and TSP-bound cells were quantitated by hemocytometer. For each of three replicate cultures, two separate hemocytometer counts were done and averaged. HEL cells were cultivated as described elsewhere.'0," Human bone marrow cell aspirates (51.0 mL to prevent peripheral dilution) were obtained after receiving informed consent and were density-separated on Ficoll-Hypaque, and adherent cells were depleted by two rounds of plastic adherence."," Importantly, these nonadherent, low density (NALD) cells do not contain megakaryocytes or platelets. The former are low density in Ficoll and thus not recovered in the mononuclear cell density band. Both residual megakaryocytes and platelets are removed by the subsequent two rounds of plastic adherence. Subsequently, these NALD cells were used in attachment assays as described above.
Hematopoietic progenitor cell attachment is determined as follows. Marrow NALD cells are cultured before (input) and after the cell attachment assay (above), as three to five replicate cultures, under optimal conditions for colony growth." For each colony cell type (ie, each lineage), replicate colony numbers are averaged. The percent attachment for each colony cell type, for each individual is calculated as the total number of adherent progenitor cells divided by the total number of input progenitor cells times 100. The results are expressed as the mean percent attachment 295% confidence interval, based on each individual's percent attachment averaged over the indicated number of experiments (n). Such calculations allow specific attachment to be determined irrespective of the known and large donor-donor variations in progenitor cell number.
Human TSP was purified from human platelets by a combination of heparinsepharose and gel filtration chromatography, a s described previously.'* Proteolytic fragments were purified as follows: The 140 Kd fragment (Fig 1) was generated by subjecting TSP to digestion with 0.1% (wt/wt) chymotrypsin (60 U/mg; Sigma Chemical Co, St Louis, MO) in 20 mmol/L Tris, pH 7.6, 0.15 mol/L NaCI, and 1 mmol/L CaCI, for 20 minutes at 37OC. The digestion was stopped by the addition of phenylmethylsulfonyl fluoride (PMSF) to a final concentration of 1 mmol/L. The resulting digest was fractionated by heparin-sepharose chromatography.I2 The nonheparin-binding 140 Kd fragment was present in the column runthrough. The 25 Kd heparin binding fragment was eluted with high salt-containing buffer (20 mmol/L Tris, pH 7.6, 0.6 mol/L NaCI). The 120 Kd/18 Kd fragment was formed by letting the chymotrypsin digestion proceed longer (40 minutes) using the same enzymembstrate ratio, temperature, and buffer as described above for the generation of the 140 Kd fragment. The nonheparin-binding 120 Kd/ 18 Kd fragment was similarly resolved from the 25 Kd heparin-binding fragment by heparin-sepharose chromatography (proteolytic fragment resolution on SDS-PAGE is shown in Fig 7, see below) . As with intact TSP, 20 pg/mL of proteolytic TSP fragments were immobilized onto tissue culture plastic, and cell attachment was done as described above. To quantitatively assess the binding of the various TSP fragments to tissue culture plastic, we used radioiodinated fragments Purification of TSP proteolytic fragments.
of known specific activity. Both the intact 140 Kd and 120/18 Kd fragments bound in equimolar amounts. The isolated 25 Kd heparinbinding domain bound in 20-fold molar excess, probably reflecting the hydrophobic character of this domain.I3
Anti-thrombospondin monoclonal antibodies. Murine monoclonal anti-TSP antibodies were prepared and purified by protein A affinity chromatography as described previously.'4-'6 These antibodies and their TSP binding domains are as follows: C6.7, which reacts with the 18 Kd fragmentt4; A6.1, A4.1, and D4.6, which react with the region proximal to the carboxy terminus of the 120 Kd fragment"; and A2.5, which reacts with the 25 Kd heparin-binding domain.16 These antibodies are specific for their stated epitopes and do not crossreact with other matrix proteins such as fibrone~tin.'~''~ Human erythroleukemia cells (1 x lo6) were metabolically labeled with "S methionine (100 pCi per dish for 6 hours) in methionine-free minimal essential medium (GIBCO) containing 10% dialyzed fetal calf serum, which had been depleted of exogenous TSP by affinity chromatography on an anti-TSP monoclonal antibody (MoAb) column. After the labeling period, the media were aspirated off the cell layer, and both detergents (1% Triton X-100, 0.5% sodium deoxycholate, and 0.1% SDS) and protease inhibitor (1 mmol/L PMSF) were added to give the indicated final concentrations. Immunoreactive TSP was precipitated with a 1:lOO dilution of polyclonal rabbit anti-TSP antiserum and protein A sepharose as described by Varani et ai.' Pre-immune rabbit serum served as control antibody. The washed immunoprecipitates were eluted by boiling in Laemmli SDS-PAGE sample buffer in the presence of 2% 2-mercaptoethanol and fractionated on a 5% Laemmli polyacrylamide gel. Radioactive bands were visualized by fluorography with En'Hance (NEN Research Products, Boston, MA) and subsequent autoradiography. Human marrow NALD cells were labeled identically, except that the cells were cultivated serum-free with 1% BSA replacing the 10% dialyzed fetal calf serum. 
org From
Hematopoietic progenitor cell assays. Human hematopoietic progenitor cell assays were done using accessory cell-depleted marrowI7 as target cells and optimal concentrations of hematopoietic growth factors.'' For progenitor cell attachment to TSP, human marrow NALD cells are attached and removed as described above, and cultured to determine the actual frequency of TSP-bound progenitors. Granulocyte and megakaryoctye progenitor cell cultures are cultivated as described by Long et al."." Erythroid and mixed cellularity progenitors were grown as described by Lim et a1.I' Progenitor cells are cultivated for 14 days at 37OC, 100% humidity, 7% CO, in room air, in the presence of hematopoietic growth factors at limiting cell dilutions of 50,000 cells/mL.
Bone marrow adherent stromal cell populations were grown in long-term bone marrow cultures for 1 to 4 weeks according to the procedure of Gartner and Kaplan.'' As described previously,20 cell-laden glass coverslips were methanol fixed, the endogenous peroxidase activity blocked with 0.03% H,O, in absolute methanol, and Fc receptors blocked with 3% goat sera. Next, the cells were incubated with polyclonal anti-TSP 1gG and antibody-localized using a biotinylated anti-IgG avidin-peroxidase Controls done each week of culture were as follows: coverslips not exposed to anti-TSP (ie, secondary antibody control), to determine nonspecific binding; and cells exposed to blocking concentrations of H,O,, to test for residual endogenous peroxidase activity.
Immunocytochemistry. (Fig 2A) . At week 2, the stromal cells are more confluent, and the attached hematopoietic cells are strongly (3-4+) positive (Fig 2B) . By week 4, TSP-positive strands of extracellular matrix are observed that are closely associated with the developing hematopoietic cells (Fig 2C) . At this time, fibroblast-like cells (which were negative early in culture) are strongly positive (data not shown). No peroxidase activity is seen in secondary antibody controls (ie, in the absence of primary antibody; Fig 2D) (Fig 3) . The extent of adherence reaches a plateau at 10 pg/dish (Fig 4) , and equilibrium binding occurs within a 15-minute time period (Fig 5) . Proteolytic fragments of TSP (as shown in Fig 1) were prepared by chymotrypsin digestion and heparin-sepharose affinity chromatography. Digestion of intact TSP by chymotrypsin for 30 minutes results in the generation of a 25 Kd heparin-binding domain and a large 140 Kd fragment. Upon further exposure to chymotrypsin, the 140 Kd fragment is cleaved to a 120 Kd and an 18 Kd fragment.14 However, the 18 Kd fragment remains in disulfide linkage to the 120 Kd species.I4
RESULTS

Thrombospondin localization in human long
The purified 140 Kd fragment contains small amounts of the 120 Kd fragment (Fig 7A, lane 2) , and the purified 120 Kd fragment contains residual (undigested) 140 Kd fragment (Fig 7A, lane 3) . These minor residual proteolytic fragments are not of significance in cellular attachment as complete cell attachment is observed only when the 140 Kd fragment is the predominant species (Fig 7C) . When the combined 120/ 18 Kd fragment is the predominant species, cells fail to bind the immobilized peptide (Fig 7C) . The antibodies (50 pg/mL) used and their specificities are described in Methods. Inapp, inappropriate antibody (murine IgG: 50 pg/mL). possible. Thrombospondin content was determined by RIA as described elsewhere.' Marrow NALD cells were washed three times in PBS and cultivated for 2 days in the presence of TSP-depleted fetal calf serum. Thrombospondin depletion was done using an affinity column containing covalently coupled MoAbdirected against TSP. Determination of TSP content in whole cell lysates of marrow NALD cells shows that large amounts of TSP (1,500 r g / lo7 cells) are produced. These RIA data were confirmed by metabolic labeling and immunoprecipitation, done as described previously: of NALD human marrow cells. Metabolic labeling studies show that significant amounts of TSP are synthesized by this nonadherent population of marrow cells, as well as by HEL cells (Fig  7D) . Moreover, metabolically labeled TSP is detectable in bone marrow (ie, NALD cell) cell conditioned media, showing that TSP is also secreted by this cell population (data not shown). also fail to bind to the 25 Kd heparin-binding domain ( Fig  7C) . Consistent with this observation, cell attachment is not inhibited by heparin (data not shown). The 140 Kd fragment contains an Arg-Gly-Asp-Ser cell recognition sequence.*' However, this particular sequence is not involved in the attachment of hematopoietic progenitor cells as a vast molar excess (1 mmol/L) of the synthetic peptide Arg-Gly-Asp-Ser fails to inhibit attachment (data not shown).
HEL cells
Inhibition of cellular attachment by monoclonal anti-TSP antibodies not only confirms the conclusions drawn from the work with proteolytic fragments, but also serves to establish the specificity of cell attachment to TSP. Treatment with MoAbs that bind proximal to the carboxy-terminal 18 Kd fragment (A 4.1, A 6.1, and D 4.615; anti-TSP antibody specificity shown in Fig 1) completely abrogates the attachment of HEL cells to TSP (Fig 3) . However, attachment is unaffected by the presence of MoAbs (A 2.5) that bind the 25 Kd heparin-binding domain,I6 the 18 Kd (C 6.7) plateletbinding fragment,14 or inappropriate antibody controls (Fig   3) .
Unfortunately, purification of primary hematopoietic progenitor cells in quantities sufficient for biochemical determinations is not technically feasible. However, radioimmunoassays (RIAs) of whole marrow (NALD) cell lysates are
DISCUSSION
We conclude that thrombospondin, a well-characterized extracellular matrix (ECM) protein is synthesized by bone marrow cells and deposited within the ECM, and it functions within the hematopoietic microenvironment as a cytoadhesion protein for hematopoietic cells. Both pluripotent and committed progenitor cells bind to this molecule. The ability to use TSP as an attachment molecule is lost in mature erythroid cells but is retained in a proportion of mature neutrophils, although the variability in neutrophil binding makes the degree of reduction difficult to interpret. Meta- itor cells (CFC-GEMM) Attachment studies using TSP proteolytic fragments indicate that the 140 Kd proteolytic fragment contains the intact cell binding domain, whereas the 120/ 18 Kd disulfide-linked fragment fails to support cell adhesion. Since both the 140 Kd and 120 Kd fragments share a common amino terminal sequence:* it follows that proteolysis must occur at the carboxy terminus of the 140 Kd fragment, resulting in both the formation of the disulfide linked 120/18 Kd fragment and loss of the ability to support cell adhesion. Consistent with this observation, antibodies that bind close to the site of proteolytic cleavage (ie, the site that results in generation of the 120/18 Kd fragment; Fig 1, asterisk) are capable of inhibiting cell attachment to TSP. Mechanistically, the anti-TSP antibodies specifically bind to an area of the TSP molecule that would span a t least 65 to 70 Kd, thus sterically inhibiting the binding of cells in an area that is much larger than the actual hematopoietic cell binding site. However, the proteolytic cleavage data further localizes the binding region to a region spanning approximately 20 to 40 amino acids just adjacent to the carboxy terminus. Whether this cleavage site represents the actual location of the cell-binding domain is presently being investigated.
Thrombospondin contains an RGDS sequence that resides within the 140 Kd fragment, near the carboxy terminus. However, excess concentrations of a tetrapeptide containing this sequence fail to abrogate cell attachment. Similar results are seen in other cell system^,'^.'^ indicating that this sequence does not play a role in cellular attachment for this molecule. In addition to hematopoietic cell attachment, the 140 Kd fragment also supports the attachment and spreading of squamous carcinoma cells and keratin~cytes.'~ In contrast, the 140 Kd fragment supports only the attachment of melanoma cells to TSP; spreading requires the additional presence of the 25 Kd heparin-binding d~m a i n . '~ Thus, cellular responsiveness to TSP binding is highly dependent on cell phenotype.
The functional role of cytoadhesion molecules in the hematopoietic microenvironment is not well understood. To date, hematopoietic cells are known to specifically attach to three cytoadhesion proteins. Fibronectin, a ubiquitous ECM protein, mediates the attachment of many hematopoietic cell lines.25 The capacity to attach to fibronectin is developmentally regulated during e r y t h r o p o i e~i s~~.~~.~~ and also occurs in human erythroid progenitor cells,30 and attachment is required for murine erythroleukemia cell differentiati~n.~' Recently, a novel cytoadhesion molecule, hemonectin, was described. Hemonectin is restricted to the bone marrow in its organ distribution and shows a developmentally regulated, lineage-specific attachment of granulocytic cells.'* Finally, thrombospondin must be added to this category of hematopoietic cytoadhesion molecules and is the first molecule shown to attach pluripotent hematopoietic progenitor cells, as well as committed progenitor cells of each lineage.
Given the ubiquitous distribution of both fibronectin and thrombospondin, the question arises as to how specificity of either progenitor cell attachment or stem cell homing occurs. For cellular attachment, specificity may be regulated either at the level of receptor expression or receptor avidity. Stem cell homing, however, requires a highly specific recognition system. A number of recent studies demonstrate that lymphocyte homing involves specific interactions with vascular endothelial cell molecules (addressins) that import positional information to recirculating lymphocytes (reviewed in reference 39). The receptor for these addressins appears to be a lectin that recognizes phosphomannose?' Less is understood concerning hematopoietic stem cell trafficking (homing). Interestingly, work by Aizawa and Tavassoli demonstrates that the homing receptor is a mannose/glactose specific lectin receptor!' Unfortunately, hematopoietic addressins remain unidentified. Surely, these will be distinct from tissue nonspecific molecules, such as thrombospondin or fibronectin. Perhaps the role for TSP and other hematopoietic cytoadhesion molecules is to strengthen the eventual localization (bond) to the appropriate microenvironmental niche. Clearly, further studies are required to understand the role of thrombospondin and other cytoadhesion molecules in hematopoiesis and bone marrow transplantation.
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